Literature DB >> 30920299

Translational and transcriptional responses in human primary hepatocytes under hypoxia.

Gaya K Hettiarachchi1, Upendra K Katneni1, Ryan C Hunt1, Jacob M Kames1, John C Athey1, Haim Bar2, Zuben E Sauna1, Joseph R McGill1, Juan C Ibla3, Chava Kimchi-Sarfaty1.   

Abstract

The liver is the primary source of a large number of plasma proteins and plays a critical role in multiple biological processes. Inadequate oxygen supply characterizing various clinical settings such as liver transplantation exposes the liver to hypoxic conditions. Studies assessing hypoxia-induced global translational changes in liver are lacking. Here, we employed a recently developed ribosome-profiling technique to assess global translational responses of human primary hepatocytes exposed to acute hypoxic stress (1% O2) for the short term. In parallel, transcriptome profiling was performed to assess mRNA expression changes. We found that translational responses appeared earlier and were predominant over transcriptional responses. A significant decrease in translational efficiency of several ribosome genes indicated translational inhibition of new ribosome protein synthesis in hypoxia. Pathway enrichment analysis highlighted altered translational regulation of MAPK signaling, drug metabolism, oxidative phosphorylation, and nonalcoholic fatty liver disease pathways. Gene Ontology enrichment analysis revealed terms related to translation, metabolism, angiogenesis, apoptosis, and response to stress. Transcriptional induction of genes encoding heat shock proteins was observed within 30 min of hypoxia. Induction of genes encoding stress response mediators, metabolism regulators, and proangiogenic proteins was observed at 240 min. Despite the liver being the primary source of coagulation proteins and the implicated role of hypoxia in thrombosis, limited differences were observed in genes encoding coagulation-associated proteins. Overall, our study demonstrates the predominance of translational regulation over transcription and highlights differentially regulated pathways or biological processes in short-term hypoxic stress responses of human primary hepatocytes. NEW & NOTEWORTHY The novelty of this study lies in applying parallel ribosome- and transcriptome-profiling analyses to human primary hepatocytes in hypoxia. To our knowledge, this is the first study to assess global translational responses using ribosome profiling in hypoxic hepatocytes. Our results demonstrate the predominance of translational responses over transcriptional responses in early hepatic hypoxic stress responses. Furthermore, our study reveals multiple pathways and specific genes showing altered regulation in hypoxic hepatocytes.

Entities:  

Keywords:  hypoxia; liver; ribosome profiling; transcriptome profiling; translational and transcriptional responses

Mesh:

Substances:

Year:  2019        PMID: 30920299      PMCID: PMC6620582          DOI: 10.1152/ajpgi.00331.2018

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  83 in total

Review 1.  Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress.

Authors:  Kyra J Cowan; Kenneth B Storey
Journal:  J Exp Biol       Date:  2003-04       Impact factor: 3.312

Review 2.  Regulation of angiogenesis by hypoxia: role of the HIF system.

Authors:  Christopher W Pugh; Peter J Ratcliffe
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

3.  Hypoxia-induced activation of p38 mitogen-activated protein kinase and phosphatidylinositol 3'-kinase signaling pathways contributes to expression of interleukin 8 in human ovarian carcinoma cells.

Authors:  Lei Xu; Pooja S Pathak; Dai Fukumura
Journal:  Clin Cancer Res       Date:  2004-01-15       Impact factor: 12.531

Review 4.  Hypoxia-responsive transcription factors.

Authors:  Eoin P Cummins; Cormac T Taylor
Journal:  Pflugers Arch       Date:  2005-07-09       Impact factor: 3.657

Review 5.  Coagulation disorders in liver disease.

Authors:  Lucio Amitrano; Maria A Guardascione; Vincenzo Brancaccio; Antonio Balzano
Journal:  Semin Liver Dis       Date:  2002-02       Impact factor: 6.115

6.  The effects of hypoxia on markers of coagulation and systemic inflammation in patients with COPD.

Authors:  Ramsey Sabit; Paul Thomas; Dennis J Shale; Peter Collins; Seamus J Linnane
Journal:  Chest       Date:  2010-02-12       Impact factor: 9.410

7.  Hypoxia-induced overexpression of DEC1 is regulated by HIF-1α in hepatocellular carcinoma.

Authors:  Wanshan Ma; Xiaohong Shi; Sumei Lu; Linlin Wu; Yunshan Wang
Journal:  Oncol Rep       Date:  2013-10-01       Impact factor: 3.906

Review 8.  Hypoxia inducible factors in liver disease and hepatocellular carcinoma: current understanding and future directions.

Authors:  Garrick K Wilson; Daniel A Tennant; Jane A McKeating
Journal:  J Hepatol       Date:  2014-08-23       Impact factor: 25.083

9.  An oxygen-regulated switch in the protein synthesis machinery.

Authors:  James Uniacke; Chet E Holterman; Gabriel Lachance; Aleksandra Franovic; Mathieu D Jacob; Marc R Fabian; Josianne Payette; Martin Holcik; Arnim Pause; Stephen Lee
Journal:  Nature       Date:  2012-05-06       Impact factor: 49.962

10.  Genome-wide identification of hypoxia-inducible factor binding sites and target genes by a probabilistic model integrating transcription-profiling data and in silico binding site prediction.

Authors:  Amaya Ortiz-Barahona; Diego Villar; Nuria Pescador; Jorge Amigo; Luis del Peso
Journal:  Nucleic Acids Res       Date:  2010-01-08       Impact factor: 16.971

View more
  6 in total

1.  Preferential Ribosome Loading on the Stress-Upregulated mRNA Pool Shapes the Selective Translation under Stress Conditions.

Authors:  Yan Chen; Min Liu; Zhicheng Dong
Journal:  Plants (Basel)       Date:  2021-02-05

2.  A Single Synonymous Variant (c.354G>A [p.P118P]) in ADAMTS13 Confers Enhanced Specific Activity.

Authors:  Ryan Hunt; Gaya Hettiarachchi; Upendra Katneni; Nancy Hernandez; David Holcomb; Jacob Kames; Redab Alnifaidy; Brian Lin; Nobuko Hamasaki-Katagiri; Aaron Wesley; Tal Kafri; Christina Morris; Laura Bouché; Maria Panico; Tal Schiller; Juan Ibla; Haim Bar; Amra Ismail; Howard Morris; Anton Komar; Chava Kimchi-Sarfaty
Journal:  Int J Mol Sci       Date:  2019-11-15       Impact factor: 5.923

3.  Muscleblind-like 2 controls the hypoxia response of cancer cells.

Authors:  Sandra Fischer; Antonella Di Liddo; Katarzyna Taylor; Jamina S Gerhardus; Krzysztof Sobczak; Kathi Zarnack; Julia E Weigand
Journal:  RNA       Date:  2020-03-03       Impact factor: 4.942

4.  Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models.

Authors:  Peter Jianrui Liu; James M Harris; Emanuele Marchi; Valentina D'Arienzo; Thomas Michler; Peter A C Wing; Andrea Magri; Ana Maria Ortega-Prieto; Maarten van de Klundert; Jochen Wettengel; David Durantel; Marcus Dorner; Paul Klenerman; Ulrike Protzer; Efstathios S Giotis; Jane A McKeating
Journal:  Sci Rep       Date:  2020-08-24       Impact factor: 4.379

5.  Effects of codon optimization on coagulation factor IX translation and structure: Implications for protein and gene therapies.

Authors:  Aikaterini Alexaki; Gaya K Hettiarachchi; John C Athey; Upendra K Katneni; Vijaya Simhadri; Nobuko Hamasaki-Katagiri; Puja Nanavaty; Brian Lin; Kazuyo Takeda; Darón Freedberg; Dougald Monroe; Joseph R McGill; Robert Peters; Jacob M Kames; David D Holcomb; Ryan C Hunt; Zuben E Sauna; Amy Gelinas; Nebojsa Janjic; Michael DiCuccio; Haim Bar; Anton A Komar; Chava Kimchi-Sarfaty
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

6.  Ribosome profiling of HEK293T cells overexpressing codon optimized coagulation factor IX.

Authors:  Aikaterini Alexaki; Jacob Kames; Gaya K Hettiarachchi; John C Athey; Upendra K Katneni; Ryan C Hunt; Nobuko Hamasaki-Katagiri; David D Holcomb; Michael DiCuccio; Haim Bar; Anton A Komar; Chava Kimchi-Sarfaty
Journal:  F1000Res       Date:  2020-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.